Compare · ELV vs LMRI
ELV vs LMRI
Side-by-side comparison of Elevance Health Inc. (ELV) and Lumexa Imaging Holdings Inc. (LMRI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and LMRI operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.84B, about 65.2x LMRI ($1.42B).
- LMRI has been more active in the news (5 items in the past 4 weeks vs 4 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 11 for LMRI).
- Company
- Elevance Health Inc.
- Lumexa Imaging Holdings Inc.
- Price
- -
- -
- Market cap
- $92.84B
- $1.42B
- 1M return
- +0.28%
- -
- 1Y return
- +29.86%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 4
- 5
- Recent ratings
- 23
- 11
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- AM Best Assigns Indicative Issue Credit Ratings to Elevance Health, Inc.’s New Shelf Registration
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Digital Info Ofr Lavu Ratnakar sold $572,000 worth of shares (1,300 units at $440.00), decreasing direct ownership by 8% to 14,849 units (SEC Form 4)
- SEC Form S-3ASR filed by Elevance Health Inc.
- EVP & CFO Kaye Mark sold $4,658,357 worth of shares (10,584 units at $440.13) (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Names Jeff Park President of Carelon
- SEC Form 8-K filed by Elevance Health Inc.
- Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
- The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
Latest LMRI
- SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.
- Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint Venture
- Lumexa Imaging Announces Third Quarter 2026 Results
- Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call Date
- Truist initiated coverage on Lumexa Imaging Holdings with a new price target
- KeyBanc Capital Markets initiated coverage on Lumexa Imaging Holdings with a new price target
- Lumexa Imaging Announces Participation in Upcoming Investor Conferences
- SEC Form SCHEDULE 13G filed by Lumexa Imaging Holdings Inc.
- SEC Form 10-Q filed by Lumexa Imaging Holdings Inc.